Refinement of response assessment in neuro-oncology (RANO) using non-enhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas

BACKGROUND: Updated response assessment in neuro-oncology (RANO) does not consider peritumoral non-enhancing lesion (NEL) and baseline (residual) contrast enhancement (CE) volume. The objective of this study is to explore helpful imaging characteristics to refine RANO for assessing early treatment r...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Hye Hyeon, Kim, Ho Sung, Park, Ji Eun, Kim, Young-Hoon, Kim, Jeong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170938/
https://www.ncbi.nlm.nih.gov/pubmed/34074252
http://dx.doi.org/10.1186/s12885-021-08414-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170938/
https://www.ncbi.nlm.nih.gov/pubmed/34074252
http://dx.doi.org/10.1186/s12885-021-08414-2

Ejemplares similares